Cardiovascular Drugs Not Tied to Cognitive Impairment

This article originally appeared here.
Share this content:
The researchers found that there was no evidence of an independent correlation between impaired cognitive function and antihypertensive use.
The researchers found that there was no evidence of an independent correlation between impaired cognitive function and antihypertensive use.

(HealthDay News) — For older adults, there is no association between cardiovascular medication use and cognitive impairment, according to a study published online in Cardiovascular Therapeutics.

Daniela Rohde, from the Royal College of Surgeons in Dublin, and colleagues examined the correlation between cardiovascular medication use and cognitive impairment in an analysis of 1903 participants (age 50 years and older) from wave 1 of the Irish Longitudinal Study on Ageing. The authors calculated cardiovascular medication use by using the proportion of days covered for antihypertensive, antithrombotic, and lipid-modifying medications.

The researchers found that there was no evidence of an independent correlation between impaired cognitive function and antihypertensive use (good adherence odds ratio, 1.16 [95% confidence interval, 0.88 to 1.52]; poor adherence odds ratio, 1.39 [95 percent confidence interval, 0.95 to 2.04]), antithrombotic use (good adherence odds ratio, 1.26 [95% confidence interval, 0.93 to 1.7]; poor adherence odds ratio, 1.13 [95% confidence interval, 0.8 to 1.59]), or lipid-modifying agent use (good adherence odds ratio, 0.95 [95% confidence interval, 0.71 to 1.25]; poor adherence odds ratio, 0.88 [95% confidence interval, 0.64 to 1.22]) after controlling for demographic and health variables.

"We found no evidence of an association between cardiovascular medication use and cognitive function," the authors write. "Future studies should investigate the prospective associations between cognition and use of cardiovascular medications using longitudinal data."

One author disclosed financial ties to the pharmaceutical industry.

Reference

  1. Rohde D, Hickey A, Williams D, Bennett K. Cognitive impairment and cardiovascular medication use: Results from Wave 1 of The Irish Longitudinal Study on Ageing. Cardiovasc Ther. 2017 Aug 24. doi: 10.1111/1755-5922.12300

Related Slideshows

You must be a registered member of Renal and Urology News to post a comment.

Newsletter Signup